deltatrials
Recruiting PHASE2/PHASE3 INTERVENTIONAL 2-arm NCT03755739

Trans-Artery/Intra-Tumor Infusion of Checkpoint Inhibitors Plus Chemodrug for Immunotherapy of Advanced Solid Tumors

A Phase II/III Trial of Comparison of Benefit of Administration of Checkpoint Inhibitors Plus Chemodrug Via Artery or Fine Needle to Tumor Versus Vein for Immunotherapy of Advanced Solid Tumors

Sponsor: Second Affiliated Hospital of Guangzhou Medical University

Conditions Breast Cancer Cervical Cancer Colo-rectal Cancer Head and Neck Cancer Hepatocarcinoma Lung Cancer Melanoma Ovarian Cancer Pancreas Cancer Renal Cancer
Interventions Checkpoint inhibitor (CPI) such as Pembrolizumab plus chemotherapy
Updated 7 times since 2018 Last updated: Jun 22, 2024 Started: Nov 1, 2018 Primary completion: Nov 1, 2033 Completion: Nov 1, 2036
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2/PHASE3 trial investigates Breast Cancer and Cervical Cancer and is currently actively recruiting participants. Second Affiliated Hospital of Guangzhou Medical University leads this study, which shows 7 recorded versions since 2018 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Dec 2018 – ~Jan 2020 · 13 months · monthly snapshotRecruiting~Jan 2020 – ~Mar 2020 · 2 months · monthly snapshotRecruiting~Mar 2020 – ~Jan 2021 · 10 months · monthly snapshotRecruiting~Jan 2021 – ~Mar 2023 · 26 months · monthly snapshotRecruiting~Mar 2023 – ~Jul 2024 · 16 months · monthly snapshotRecruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotRecruiting~Sep 2024 – present · 22 months · monthly snapshotRecruiting

Change History

7 versions recorded

  1. Sep 2024 — Present [monthly]

    Recruiting PHASE2/PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Recruiting PHASE2/PHASE3

    Phase: PHASE2_PHASE3 → PHASE2/PHASE3

  3. Mar 2023 — Jul 2024 [monthly]

    Recruiting PHASE2_PHASE3

  4. Jan 2021 — Mar 2023 [monthly]

    Recruiting PHASE2_PHASE3

  5. Mar 2020 — Jan 2021 [monthly]

    Recruiting PHASE2_PHASE3

▶ Show 2 earlier versions

  1. Jan 2020 — Mar 2020 [monthly]

    Recruiting PHASE2_PHASE3

    Phase: NA → PHASE2_PHASE3

  2. Dec 2018 — Jan 2020 [monthly]

    Recruiting NA

    First recorded

Nov 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Second Affiliated Hospital of Guangzhou Medical University
Data source: Second Affiliated Hospital of Guangzhou Medical University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations